Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danilo Fliser

Showing results (271-280 of 293) with videos related to

Pageof 30
Sort By:
European Heart Journal|August 8, 2015
Serum amyloid A: high-density lipoproteins interaction and cardiovascular riskStephen Zewinger, Christiane Drechsler, Marcus E Kleber, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 2021
Orphan nuclear receptor ERR-γ regulates hepatic FGF23 production in acute kidney injuryKamalakannan Radhakrishnan, Yong-Hoon Kim, Yoon Seok Jung, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 5, 2020
Funding kidney research as a public health priority: challenges and opportunitiesCarmine Zoccali, Raymond Vanholder, Carsten A Wagner, et al.
Immunity|March 13, 2013
Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2Thimoteus Speer, Lucia Rohrer, Przemyslaw Blyszczuk, et al.
The Lancet. Child & Adolescent Health|April 29, 2023
Urinary DKK3 as a biomarker for short-term kidney function decline in children with chronic kidney disease: an observational cohort studyThimoteus Speer, Stefan J Schunk, Tamim Sarakpi, et al.
Proteomics. Clinical Applications|February 5, 2010
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnosticsJoshua J Coon, Petra Zürbig, Mohammed Dakna, et al.
European Heart Journal|April 6, 2017
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular diseaseStephen Zewinger, Marcus E Kleber, Lucia Rohrer, et al.
Circulation|July 1, 2021
Interleukin-1α Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney DiseaseStefan J Schunk, Sarah Triem, David Schmit, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 10, 2019
Mild cognitive impairment and kidney disease: clinical aspectsDavide Viggiano, Carsten A Wagner, Peter J Blankestijn, et al.
Proteomics. Clinical Applications|December 8, 2010
Clinical proteomics: A need to define the field and to begin to set adequate standardsHarald Mischak, Rolf Apweiler, Rosamonde E Banks, et al.
Pageof 30

Showing results (271-280 of 293) with videos related to

Sort By:
Pageof 30
European Heart Journal|August 8, 2015
Serum amyloid A: high-density lipoproteins interaction and cardiovascular riskStephen Zewinger, Christiane Drechsler, Marcus E Kleber, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 2021
Orphan nuclear receptor ERR-γ regulates hepatic FGF23 production in acute kidney injuryKamalakannan Radhakrishnan, Yong-Hoon Kim, Yoon Seok Jung, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 5, 2020
Funding kidney research as a public health priority: challenges and opportunitiesCarmine Zoccali, Raymond Vanholder, Carsten A Wagner, et al.
Immunity|March 13, 2013
Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2Thimoteus Speer, Lucia Rohrer, Przemyslaw Blyszczuk, et al.
The Lancet. Child & Adolescent Health|April 29, 2023
Urinary DKK3 as a biomarker for short-term kidney function decline in children with chronic kidney disease: an observational cohort studyThimoteus Speer, Stefan J Schunk, Tamim Sarakpi, et al.
Proteomics. Clinical Applications|February 5, 2010
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnosticsJoshua J Coon, Petra Zürbig, Mohammed Dakna, et al.
European Heart Journal|April 6, 2017
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular diseaseStephen Zewinger, Marcus E Kleber, Lucia Rohrer, et al.
Circulation|July 1, 2021
Interleukin-1α Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney DiseaseStefan J Schunk, Sarah Triem, David Schmit, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 10, 2019
Mild cognitive impairment and kidney disease: clinical aspectsDavide Viggiano, Carsten A Wagner, Peter J Blankestijn, et al.
Proteomics. Clinical Applications|December 8, 2010
Clinical proteomics: A need to define the field and to begin to set adequate standardsHarald Mischak, Rolf Apweiler, Rosamonde E Banks, et al.
Pageof 30